We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Foundation Medicine to Develop Companion Diagnostics for Lilly’s Cancer Drugs
Foundation Medicine to Develop Companion Diagnostics for Lilly’s Cancer Drugs
Cambridge, Mass.-based Foundation Medicine has teamed up with Eli Lilly for the development of tissue- and blood-based assays as companion diagnostics for Lilly’s cancer drug Retevmo and other therapies.